ReproCELL Incorporated
4978.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.33 | 4.79 | 1.27 | 0.90 |
| FCF Yield | -0.59% | -1.51% | -1.49% | -1.71% |
| EV / EBITDA | 113.05 | 1,280.89 | -72.21 | -28.57 |
| Quality | ||||
| ROIC | -1.44% | -4.89% | -4.68% | -8.81% |
| Gross Margin | 55.27% | 46.18% | 38.64% | 35.96% |
| Cash Conversion Ratio | 0.06 | 0.40 | 0.46 | 0.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.29% | 2.79% | 31.92% | 23.03% |
| Free Cash Flow Growth | 60.56% | 32.39% | -2.48% | 58.74% |
| Safety | ||||
| Net Debt / EBITDA | -29.48 | -356.47 | 7.52 | 4.99 |
| Interest Coverage | 0.00 | 0.00 | -4,452.80 | -1,892.18 |
| Efficiency | ||||
| Inventory Turnover | 4.93 | 5.26 | 7.73 | 5.52 |
| Cash Conversion Cycle | 94.97 | 85.14 | 60.59 | 48.15 |